Sentinel Lymph Node Biopsy Clinical Trial
Official title:
Impact of Sentinel Lymph Node Biopsy After Neoadjuvant Treatment on Locoregional Control of Disease in Initially Node Positive Breast Cancer Patients
From May 2016 till May 2018 all breast cancer patients with operable disease submitted to surgery after neoadjuvant treatment would be divided in four groups considering initially clinical axillary stage, axillary procedure that was done, axillary response to preoperative systemic treatment and pathological axillary stage. In first postoperative year all patients will be monitored for appearance of locoregional and distant recurrence.
From May 2017 SLNB after neoadjuvant treatment was introduced in clinical practice for breast cancer patients presenting initially with involved axilla but shifted to clinically negative followed neoadjuvant treatment. This retrospective analysis is designed for period of one year before and one year later to compare the clinical outcomes for this patients in the setting where ALND was performed to the setting where SLNB was performed. The main hypothesis was to establish that SLNB after neoadjuvant treatment, in initially node positive breast cancer patients that achieve complete clinical remission following neoadjuvant treatment, is reliable alternative to ALND in maintenance of locoregional control of disease. For the purpose of this trial four groups were created and the results would be compared among them. In first postoperative year patients were monitored for the appearance of locoregional and distant recurrence. Data were collected individually for each patient and recorded in register. All data are available to all members of investigation team, members of Ethic Committee and statistician. Data collected in this trial would be used for publication. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03719833 -
Sentinel Lymph Node Biopsy After Neoadjuvant Treatment in Breast Cancer Patents
|
||
Recruiting |
NCT00654342 -
Comparison Between ex Vivo and in Vivo Injection of Blue Dye in Sentinel Lymph Node Mapping for Colon Cancer
|
N/A | |
Not yet recruiting |
NCT04140188 -
SLNB After Nipple Sparing Mastectomy
|
N/A | |
Recruiting |
NCT01564264 -
Sentinel Node Biopsy in Endometrial Cancer
|
N/A | |
Recruiting |
NCT06212440 -
Clinical Application of Multi-modal Sentinel Lymph Node Staining Method in Breast Cancer Patients After Neoadjuvant Chemotherapy
|
N/A | |
Terminated |
NCT03630653 -
Sentinel Lymph Node Procedure in Ipsilateral Invasive Breast Cancer Relapse
|
N/A | |
Active, not recruiting |
NCT04986306 -
The Validation of Sentinel Lymph Node Biopsy After Neo-adjuvant Chemotherapy in Breast Cancer Patients
|
||
Recruiting |
NCT05512468 -
Application of Preoperative Axillary Lymph Node Marking With Nano-Carbon in Breast Cancer Patients Before Neoadjuvant Chemotherapy
|
N/A | |
Recruiting |
NCT03199560 -
Tilmanocept vs Sulfur Colloid in Sentinel Lymph Node Biopsy
|
Phase 4 | |
Not yet recruiting |
NCT04932460 -
Contrast-enhanced Ultrasonography Combined With Blue Dye as Dual-tracer for Sentinel Lymph Node Biopsy
|
N/A | |
Recruiting |
NCT03680833 -
Sentinel Node Detection in Cervical Cancer
|
N/A | |
Completed |
NCT03200704 -
A Study Assessing the Safety and Effectiveness of IC2000 and SPY Fluorescence Imaging Systems (SPY-PHI) in the Visualization of Lymphatic Vessels and Identification of Lymph Nodes During Sentinel Lymph Node Biopsy in Subjects With Breast Cancer
|
Phase 3 | |
Recruiting |
NCT04403867 -
The Role of Micrometastasis and Isolated Tumor Cells (ITCs) in Endometrial and Cervical Cancer. A Multicenter Study.
|
||
Not yet recruiting |
NCT05703295 -
Oncologic Safety of Sentinel Lymph Node Biopsy in Clinically Palpable Axillary Lymph Node in Breast Cancer Patients
|
||
Enrolling by invitation |
NCT05942170 -
The Combination of Preoperative MRI and SLN in the Surgical Management of CC and EC
|
N/A | |
Recruiting |
NCT03937414 -
Intraoperative Molecular Diagnosis of Sentinel Lymph Node In Breast Cancer Patients
|
N/A | |
Recruiting |
NCT06120439 -
Comparing the QoR of PECS Block and GA in Breast-conserving Surgery With Sentinel Lymph Node Biopsy
|
N/A | |
Terminated |
NCT05457842 -
A Study to Find the Best Dose of ASP5354 to Show Lymph Nodes in People With Breast Cancer or Melanoma During Surgery
|
Phase 2 |